Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Clinical results reported for rhIGF-I in ALS patients

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims new indication for olanzapine

Nov. 26, 1996

Worldwide rights offered for protein inducing oligodendroglia mitosis

Nov. 26, 1996

Novel antipsychotic drug now available in U.K.

Nov. 26, 1996

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Three additional approvals for Rilutek

Nov. 25, 1996

Marinol promising for geriatric AD

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...